Actionable news
All posts from Actionable news
Actionable news in MACK: Merrimack Pharmaceuticals, Inc.,

FDA clears Merrimack's pancreatic cancer drug with warning

* FDA approves pancreatic cancer therapy

* Treatment to carry black box warning

* Stock halted (Adds background, analyst's comment)

Oct 22 (Reuters) - The U.S. Food and Drug Administration approved Merrimack Pharmaceutical Inc's pancreatic cancer therapy Onivyde, but with a serious warning, marking the company's first ever drug to win regulatory clearance.

The drug in combination with chemotherapy treatments 5-fluorouracil and leucovorin treats metastatic pancreatic cancer in patients, who have failed to respond to chemotherapy drug...